Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperfractionated radiotherapy for lung cancer.

E L Gressen1, W J Curran

  • 1Department of Radiation Oncology, Frankford Hospital Torresdale Division, Knights and Red Lion Roads, Philadelphia, PA 19114, USA.

Current Oncology Reports
|December 21, 2000
PubMed
Summary

Hyperfractionated radiation therapy improves survival for lung cancer patients. Combining it with chemotherapy and advanced techniques may further enhance outcomes while managing toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC).

International journal of radiation oncology, biology, physics·2021
Same author

Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia.

International journal of radiation oncology, biology, physics·2021
Same author

Pseudo CT Estimation using Patch-based Joint Dictionary Learning.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2018
Same author

Factors influencing choice of balsam fir twigs from thinned and unthinned stands by moose.

Oecologia·2017
Same author

Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis.

Cell death and differentiation·2014
Same author

Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.

Oncogene·2013

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • Conventional radiotherapy has limitations in treating advanced lung cancers.
  • Hyperfractionated or accelerated hyperfractionated thoracic radiation therapy shows promise in recent clinical trials.
  • Stage III non-small-cell lung cancer and limited-stage small-cell lung cancer remain significant health challenges.

Purpose of the Study:

  • To review the efficacy of hyperfractionated radiotherapy in lung cancer.
  • To explore the potential of combining novel chemotherapy with advanced radiotherapy techniques.
  • To discuss strategies for minimizing toxicity and enabling therapeutic escalation.

Main Methods:

  • Review of recent clinical trial data on hyperfractionated and accelerated hyperfractionated thoracic radiation therapy.
  • Analysis of potential benefits and toxicities of combining novel chemotherapy agents (taxanes, gemcitabine) with radiotherapy.
  • Evaluation of normal tissue sparing techniques like 3D treatment planning and radioprotectors (amifostine).

Main Results:

  • Hyperfractionated or accelerated hyperfractionated thoracic radiation therapy has demonstrated improved survival compared to conventional radiotherapy for specific lung cancer stages.
  • Combinations with novel chemotherapy agents may offer further survival benefits.
  • Minimizing radiation to normal tissues through advanced planning or radioprotectors could allow for treatment intensification.

Conclusions:

  • Advanced radiotherapy techniques, particularly hyperfractionation, are effective in improving survival for non-small-cell and small-cell lung cancer.
  • Chemoradiation strategies incorporating novel agents and toxicity-reducing methods hold potential for better lung cancer treatment outcomes.
  • Further research into therapeutic escalation with minimized normal tissue exposure is warranted to combat lung cancer mortality.

Related Experiment Videos